Journal of Medical Marketing (2007) 7, 263–264. doi:10.1057/palgrave.jmm.5050091
Case Commentary
Kerry Gilzene1
1was born in London and graduated with a BEng (Hons) Biochemical Engineering in 1991. His career spans over 16 years, including GSK (Worldwide Strategic Marketing), EVP of Aptilon Health (e detailing, CRM and ROI) and Ogilvy Healthworld (Marketing Consultancy). He is currently General Manager of DDB Health Asia based out of Singapore. He is a recognised international speaker on the subject of 1 to 1 pharma marketing and interactive CRM strategies, and has produced several publications on the subject. He has lectured at both INSEAD (MBA Pharma Marketing Module) and the University of Brussels (Pharma Marketing for Scientists).

